Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread
Automated news aggregation. Headlines and summaries are gathered from public feeds; see our editorial standards for sourcing, corrections, and AI-assist disclosure.
Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.
About this story
This story was aggregated from Al Jazeera. Headlines, summaries, and links are gathered automatically from public RSS feeds for your convenience.
Read the full story →For agents:JSON recordOpenAPIWebMCPllms.txt